BSX
Boston Scientific Corporation (BSX)
Last Price$104.91.0%
Market Cap$154.5B
Last Earnings date
Sep'24
Q3 2024
$0.00
100.0% miss
$4,561.0M
3.2% beat
Next quarter EPS Estimate
$0.65
18.2%YoY

BSX Earnings and Expectations

Revenue

Crunching data... Almost there!

BSX EPS (Earnings Per Share)

Crunching data... Almost there!

BSX Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$1,000.0M$2,000.0M$3,000.0M$4,000.0M$5,000.0MApr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24Oct'24$2,543.0M$2,659.0M$2,752.0M$2,932.0M$3,026.0M$3,170.0M$3,389.0M$3,527.0M$3,856.0M$4,209.0M
Value Sense
Actual Revenue
Forecast Revenue

BSX Earnings History

Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$1,768.0M$1,843.0M$1,888.0M$1,978.0M$1,964.0M$2,126.0M$2,105.0M$2,191.0M$2,160.0M$2,257.0M$2,222.0M$2,408.0M$2,379.0M$2,490.0M$2,393.0M$2,561.0M$2,493.0M$2,631.0M$2,707.0M$2,905.0M$2,543.0M$2,003.0M$2,659.0M$2,708.0M$2,752.0M$3,077.0M$2,932.0M$3,127.0M$3,026.0M$3,244.0M$3,170.0M$3,242.0M$3,389.0M$3,599.0M$3,527.0M$3,725.0M$3,856.0M$4,120.0M$4,209.0M$4,561.0M
Revenue estimate$1,768.0M$1,768.0M$1,768.0M$1,768.0M$1,683.4M$1,683.4M$1,683.4M$1,683.4M$2,234.5M$2,234.5M$2,234.5M$2,234.5M$2,306.9M$2,306.9M$2,306.9M$2,306.9M$2,534.7M$2,641.9M$2,646.5M$2,900.0M$2,607.7M$1,726.9M$2,520.3M$2,812.3M$2,616.5M$2,940.1M$2,960.9M$3,111.3M$2,955.3M$3,216.4M$3,139.6M$3,243.3M$3,155.8M$3,502.5M$3,476.9M$3,593.2M$3,684.1M$4,028.8M$4,040.8M$4,421.2M
Revenue surprise0.0%4.2%6.8%11.9%16.7%26.3%25.0%30.2%3.3%1.0%0.6%7.8%3.1%7.9%3.7%11.0%1.6%0.4%2.3%0.2%2.5%16.0%5.5%3.7%5.2%4.7%1.0%0.5%2.4%0.9%1.0%0.0%7.4%2.8%1.4%3.7%4.7%2.3%4.2%3.2%
EPS actual($0.00)$0.08($0.15)($0.11)$0.15($0.15)$0.17$0.09$0.21$0.11$0.21($0.45)$0.22$0.40$0.31$0.28$0.31$0.11$0.09$2.87$0.01($0.11)($0.11)$0.11$0.24$0.13$0.29$0.07$0.07$0.17$0.12$0.09$0.21$0.18$0.34$0.34$0.34$0.22$0.32$0.00
EPS estimate$0.21$0.21$0.21$0.21$0.20$0.20$0.20$0.20$0.31$0.31$0.31$0.31$0.31$0.31$0.31$0.31$0.36$0.38$0.38$0.44$0.33($0.03)$0.25$0.31$0.31$0.37$0.40$0.44$0.38$0.42$0.44$0.47$0.43$0.49$0.48$0.51$0.51$0.58$0.59$0.66
EPS surprise100.3%63.8%171.4%152.4%25.0%175.0%15.0%54.5%32.3%64.5%32.3%245.2%29.0%29.0%0.0%9.7%12.9%71.1%76.4%553.3%97.6%324.3%144.4%64.9%21.5%65.1%26.6%85.0%82.5%59.8%72.8%81.3%51.5%63.3%28.8%33.7%33.8%62.3%45.6%100.0%

Overview of financial statements

Income statement
Balance sheet
Cash Flow statement
$4,561.0M 22.4% YoY
$3,095.0M 20.1% YoY
67.9% margin
Cost of revenue
$1,466.0M 27.8% YoY
Operating income
$675.0M 15.6% YoY
14.8% margin
Other: $117.0M
Net interest: $27.0M
Operating expenses
$2,420.0M 23.4% YoY
Pre-tax income
$585.0M 15.8% YoY
12.8% margin
Net income
$566.0M 12.1% YoY
12.4% margin
Income tax
$23.0M
3.9% tax rate
R&D
$459.0M 26.4% YoY
10.1% of revenue
SG&A
$1,612.0M 16.9% YoY
35.3% of revenue

Competing with BSX Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$154.5B
$16.7B
$0.88
22.4%
(100.0%)
Beat by 3.2%
Miss by 100.0%
(2.3%)
0.0%
Beats: 8
Misses: 2
12.2%
122.5%
$242.4B
$42.0B
$7.74
7.2%
479.3%
Miss by 0.5%
Beat by 299.2%
(2.9%)
(79.2%)
Beats: 8
Misses: 2
7.3%
(33.4%)
$150.5B
$22.6B
$7.86
10.7%
(52.5%)
Beat by 1.2%
Miss by 63.1%
(11.5%)
99.0%
Beats: 8
Misses: 2
8.0%
71.8%
$120.9B
$33.2B
$0.49
2.5%
N/A
undefinedN/A
undefinedN/A
0.4%
(175.5%)
Beats: 9
Misses: 1
3.7%
96.8%
$43.4B
$5,872.6M
$6.94
(8.5%)
715.9%
Miss by 18.1%
Beat by 640.4%
0.3%
(89.3%)
Beats: 6
Misses: 4
7.1%
(65.0%)
$34.9B
$4,033.0M
$1.47
7.6%
(43.3%)
Beat by 1.2%
Miss by 25.4%
(7.4%)
0.3%
Beats: 8
Misses: 2
14.3%
42.2%
$24.7B
€18.0B
(€0.79)
(0.4%)
N/A
Miss by 14.5%
Miss by 168.2%
(3.2%)
(215.9%)
Beats: 2
Misses: 6
10.0%
(246.6%)
$21.9B
$5,398.4M
$4.74
(1.8%)
23.9%
Miss by 0.8%
Miss by 24.2%
9.1%
48.9%
Beats: 6
Misses: 4
7.0%
138.5%
$21.6B
$5,655.4M
$3.25
(100.0%)
(100.0%)
Miss by 100.0%
Miss by 100.0%
0.0%
0.0%
Beats:
Misses:
3.7%
62.6%
$19.4B
$1,900.3M
$6.05
17.2%
(2.7%)
Beat by 2.6%
Beat by 43.5%
(9.0%)
(46.5%)
Beats: 9
Misses: 1
21.2%
8.4%

FAQ

1. When was Boston Scientific Corporation's last earnings date?

Boston Scientific Corporation's last earnings date was Sep'24 (Q3 2024).

2. What is Boston Scientific Corporation's EPS, and was there a surprise?

4. What is Boston Scientific Corporation's next quarter EPS estimate?

Boston Scientific Corporation's next quarter EPS estimate is $0.65, with an expected 18.2% YoY growth.